Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tiny sensor could unlock muscle mysteries in rare disease

NCT ID NCT06819683

First seen Feb 27, 2026 · Last updated May 23, 2026 · Updated 12 times

Summary

This study is testing a new, minimally invasive oxygen nanosensor to measure how well muscles use oxygen in people with mitochondrial myopathy (a muscle disease) and in healthy volunteers. The goal is to see if the sensor can reliably detect differences in muscle function, which could help develop better ways to diagnose and monitor the disease. 96 adults aged 18-65 will participate in this early-stage research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MITOCHONDRIAL MYOPATHIES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.